欧洲乳腺癌筛查市场预测至 2027 年 - Covid-19 影响和按测试类型（血液标记测试、影像测试、基因测试、免疫组织化学测试）、最终用户（医院、诊断中心、癌症研究所、研究实验室）和区域分析国家
No. of Pages: 155 | Report Code: TIPRE00011563 | Category: Life Sciences
No. of Pages: 155 | Report Code: TIPRE00011563 | Category: Life Sciences
2019年欧洲乳腺癌筛查市场价值为12.3182亿美元，预计到2027年将达到15.8646亿美元；预计 2020 年至 2027 年复合年增长率为 4.3%。
乳腺癌形成于乳房中的小叶、导管、脂肪组织或纤维结缔组织。因此，导管癌、小叶癌、浸润性导管癌和浸润性小叶癌是乳腺癌的常见类型。乳腺癌早期没有任何症状；然而，乳房肿块可能是乳腺癌发展的第一个迹象。
p>
不断增长的赠款和举措有利于乳腺癌筛查市场的增长。乳腺癌筛查在确定合适的程序和所需的治疗速度方面发挥着重要作用。早期筛查可降低乳腺癌死亡率；因此，市场参与者以及政府当局正在实施新的诊断或筛查设施。 。欧盟乳腺癌倡议 (ECIBC) 制定了欧洲乳腺癌指南和循证参考资料，为女性和医疗保健提供者提供有关乳腺癌筛查和诊断的明智、客观和个性化的指导。此外，政府还提供资金用于开发癌症技术检测。例如，2017 年 2 月，德国基因检测公司 CeGaT 从德国联邦教育和研究部获得了 531,615 美元（50 万欧元），用于支持开发用于分析循环肿瘤 DNA 的液体活检技术。< /p>
基于测试类型，乳腺癌筛查市场进一步细分为影像学检测、免疫组化检测、基因检测和血液标志物检测。成像测试领域在2019年占据了最大的市场份额，预计在预测期内也将实现最高的复合年增长率。
根据最终用户，乳腺癌筛查市场分为医院、诊断中心、癌症研究所和研究实验室。医院细分市场在 2019 年占据最大市场份额，预计在预测期内复合年增长率最高。
产品发布和批准是公司扩大全球足迹并满足不断增长的需求的常用策略。乳腺癌筛查市场的参与者采用扩张、合作和产品发布策略来扩大全球客户群。这些策略使参与者能够在全球范围内保持其品牌知名度。例如，2018年5月，西门子Healthineers和ScreenPoint Medical合作设计了基于人工智能的乳腺成像软件。此次联合合作还包括西门子 Healthineers 拥有 ScreenPoint Medical 的战略性少数股权。
;
Strategic insights for Europe Breast Cancer Screening involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,231.82 Million |
| Market Size by 2027 | US$ 1,586.46 Million |
| Global CAGR (2020 - 2027) | 4.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 检测类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Breast Cancer Screening refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Breast Cancer Screening Market
The Europe Breast Cancer Screening Market is valued at US$ 1,231.82 Million in 2019, it is projected to reach US$ 1,586.46 Million by 2027.
As per our report Europe Breast Cancer Screening Market, the market size is valued at US$ 1,231.82 Million in 2019, projecting it to reach US$ 1,586.46 Million by 2027. This translates to a CAGR of approximately 4.3% during the forecast period.
The Europe Breast Cancer Screening Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Breast Cancer Screening Market report:
The Europe Breast Cancer Screening Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Breast Cancer Screening Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Breast Cancer Screening Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Breast Cancer Screening Market
